Congenica
GenomOncology, Congenica Team up to Develop Precision Oncology Dx Platform
The firms will build on their existing technologies and seek a CE-IVD mark for a new clinical decision support system for individualized cancer therapies.
Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing
University of Glasgow spinout Gabriel Precision Oncology will contribute a bioinformatics pipeline derived from cancer tissue samples to accelerate MDx adoption.